These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 15566429)

  • 1. Down-regulation of pathogenic autoantibody response in a slowly progressive Heymann nephritis kidney disease model.
    Barabas AZ; Cole CD; Barabas AD; Lafreniere R
    Int J Exp Pathol; 2004 Dec; 85(6):321-34. PubMed ID: 15566429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of a pathogenic autoantibody response by IgM autoantibodies directed against the nephritogenic antigen in slowly progressive Heymann nephritis.
    Barabas AZ; Cole CD; Barabas AD; Lafreniere R
    Pathol Int; 2006 Apr; 56(4):181-90. PubMed ID: 16634963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of rat kidney fraction 3 (rKF3) antigen and specific IgM antibody against rKF3 on the progression of slowly progressive Heymann nephritis.
    Barabas AZ; Cole CD; Barabas AD; Barabas AN; Lafreniere R
    Pathol Int; 2006 Sep; 56(9):516-29. PubMed ID: 16930332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunopathological events initiated and maintained by pathogenic IgG autoantibodies in an experimental autoimmune kidney disease.
    Barabas AZ; Cole CD; Lafreniere R; Weir DM
    Autoimmunity; 2012 Nov; 45(7):495-509. PubMed ID: 22816962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen-specific down-regulation of immunopathological events in an experimental autoimmune kidney disease.
    Barabas AZ; Lafreniere R
    Autoimmun Rev; 2005 Nov; 4(8):565-70. PubMed ID: 16214097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of Heymann nephritis by a chemically modified renal antigen.
    Barabas AZ; Cole CD; Barabas AD; Lafreniere R
    Int J Exp Pathol; 2004 Oct; 85(5):277-85. PubMed ID: 15379960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presence of immunoglobulin M antibodies around the glomerular capillaries and in the mesangium of normal and passive Heymann nephritis rats.
    Barabas AZ; Cole CD; Barabas AD; Cowan JM; Yoon CS; Waisman DM; Lafreniere R
    Int J Exp Pathol; 2004 Oct; 85(4):201-12. PubMed ID: 15312125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies to glycolipids activate complement and promote proteinuria in passive Heymann nephritis.
    Susani M; Schulze M; Exner M; Kerjaschki D
    Am J Pathol; 1994 Apr; 144(4):807-19. PubMed ID: 8160779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of a new model of slowly progressive Heymann nephritis.
    Barabas AZ; Cole CD; Barabas AD; Lafreniere R
    Int J Exp Pathol; 2003 Dec; 84(6):245-58. PubMed ID: 14748744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The kinetics of the pathogenic pronase-digested renal proximal tubular antigen and antibody in rat active Heymann nephritis.
    Maezawa A; Tsukada Y; Yano S; Naruse T
    Nephron; 1995; 71(4):448-53. PubMed ID: 8587626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progressive passive Heymann nephritis in the rat.
    Barabas AZ; Boyd N; Cornish J; Lannigan R
    Lab Invest; 1982 Oct; 47(4):400-5. PubMed ID: 6214666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of circulating autoantibody levels in the rat with established progressive passive Heymann nephritis.
    Barabas AZ; Cornish J; Lannigan R
    Clin Exp Immunol; 1986 Jul; 65(1):34-41. PubMed ID: 3539426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential capacity of anti-RAP and anti-megalin antibodies to produce progressive passive Heymann nephritis - implications for the pathogenesis of idiopathic human membranous glomerulonephritis.
    Makker SP; Tramontano A
    J Pathol; 2006 Nov; 210(3):282-7. PubMed ID: 16981232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced incidence of slowly progressive Heymann nephritis in rats immunized with a modified vaccination technique.
    Barabas AZ; Cole CD; Barabas AD; Barabas AN; Lafreniere R
    Clin Dev Immunol; 2006 Mar; 13(1):17-24. PubMed ID: 16603441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventative and therapeutic vaccination to combat an experimental autoimmune kidney disease.
    Barabas AZ; Cole CD; Barabas AD; Lafreniere R
    Biologics; 2007 Mar; 1(1):59-68. PubMed ID: 19707349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epitope specificity of anti-gp330 autoantibodies determines the development of proteinuria in active Heymann nephritis.
    Van Leer EH; Ronco P; Verroust P; van der Wal AM; Hoedemaeker PJ; De Heer E
    Am J Pathol; 1993 Mar; 142(3):821-9. PubMed ID: 7681258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody-induced redistribution of Heymann antigen on the surface of cultured glomerular visceral epithelial cells: possible role in the pathogenesis of Heymann glomerulonephritis.
    Camussi G; Brentjens JR; Noble B; Kerjaschki D; Malavasi F; Roholt OA; Farquhar MG; Andres G
    J Immunol; 1985 Oct; 135(4):2409-16. PubMed ID: 3875653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Passive Heymann nephritis with acute and severe proteinuria induced by heterologous antibody against renal tubular brush border glycoprotein gp108.
    Natori Y; Hayakawa I; Shibata S
    Lab Invest; 1986 Jul; 55(1):63-70. PubMed ID: 3755192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA vaccination against specific pathogenic TCRs reduces proteinuria in active Heymann nephritis by inducing specific autoantibodies.
    Wu H; Walters G; Knight JF; Alexander SI
    J Immunol; 2003 Nov; 171(9):4824-9. PubMed ID: 14568961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Passive Heymann nephritis in pre- and post-natal rats.
    Challice J; Barabas AZ; Cornish J; Bruce JW; Lannigan R
    Br J Exp Pathol; 1986 Dec; 67(6):915-24. PubMed ID: 3542009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.